ストックスクリーナーアプリを入手
187.89
1.01%
-1.92
アフターアワーズ：
189.87
1.98
+1.05%
前日終値:
$189.81
開ける：
$189.81
24時間の取引高:
925.15K
Relative Volume:
1.06
時価総額：
$12.06B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
18.03
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
-3.93%
1か月 パフォーマンス:
+23.90%
6か月 パフォーマンス:
+57.65%
1年 パフォーマンス:
+39.79%
1日の値動き範囲:
$186.62
$192.06
1週間の範囲:
$186.62
$198.60
52週間の値動き範囲:
$101.00
$202.69
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
187.89 | 12.18B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
367.35 | 82.29B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
163.60 | 14.65B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
20.55 | 11.30B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
101.55 | 10.19B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): NYSE-listed dialysis provider trades around late-May levels as inv - AD HOC NEWS
Bull of the day: DaVita Inc. (DVA) - MSN
DaVita Inc. (DVA) Stock Analysis: High Return On Equity Highlights Investment Potential - DirectorsTalk Interviews
DaVita Interactive Trivia: Put your knowledge to the test with these questions - Denver7
DaVita Inc stock (US23804L1035): shares ease near late-May levels - AD HOC NEWS
DaVita Inc. stock (US23918K1088): shares ease while investors watch technical levels after recent ga - AD HOC NEWS
DaVita Inc. stock (US23918K1088): NYSE shares hold steady as investors look toward next earnings dat - AD HOC NEWS
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): shares trade sideways ahead of next earnings as valuation comes in - AD HOC NEWS
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term - Yahoo Finance
DaVita (DVA) Short Interest & Short Float | Updated Jun 2026 $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Revenue BreakdownMain Composition - Moomoo
Two Sides of the "Gift of Life" From DaVita Teammates - ACCESS Newswire
DaVita and Arcosa have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
DaVita Stock Is Up 70% YTD: What the Numbers Say About 2026 - TIKR.com
Bull of the Day: DaVita Inc. (DVA) - Zacks Investment Research
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
Hope in our Hometown: DaVita Celebrates the 2026 Transplant Games in Denver - DaVita Newsroom
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Best Growth Stocks to Buy for May 26th - The Globe and Mail
Zacks.com featured highlights include DaVita, Integra LifeSciences, Braskem and LyondellBasell - Yahoo Finance
Is DaVita (DVA) Stock Undervalued Right Now? - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Navigating Growth in Healthcare with Strong ROE and Strategic Positioning - DirectorsTalk Interviews
DaVita stock (US23918K1088): dialysis giant faces regulatory overhang after strong rally - AD HOC NEWS
DaVita’s Nurse Awards And Community Goals Set Against Hot Share Rally - Sahm
What DaVita (DVA)'s 2030 Community Care Goals and Upgraded Outlook Mean For Shareholders - Yahoo Finance
DaVita Honors 57 DAISY Nurses As Investors Weigh Workforce And Valuation - Yahoo Finance
DaVita stock (US23918K1088): Q4 2025 revenue beat and debt load stay in focus - AD HOC NEWS
Here's why you should retain DaVita stock in your portfolio for now - MSN
DaVita Honors Extraordinary Nurses With the 2026 DAISY Awards - ACCESS Newswire
Beyond the Clinical: How Social Workers Drive Kidney Transplant Success - DaVita Newsroom
DaVita stock (US23918K1088): solid Q1 2025 earnings keep dialysis specialist in focus - AD HOC NEWS
DaVita Inc stock (US23804L1035): earnings, buyback and outlook after strong first quarter - AD HOC NEWS
AI shows promise as health systems invest in chronic disease tech - Modern Healthcare News
DaVita ESG Roadmap Links 2030 Care Goals To Core Operations - Yahoo Finance
DaVita’s SWOT analysis: healthcare stock faces growth amid volatility By Investing.com - Investing.com South Africa
DaVita’s SWOT analysis: healthcare stock faces growth amid volatility - Investing.com
DaVita Inc. Lifts Outlook After Q1 Earnings Beat - TipRanks
DaVita stock (US23918K1088): Insider sale follows strong Q1 2026 earnings - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals - Sahm
Best Value Stocks to Buy for May 19th - Yahoo Finance Australia
DaVita stock (US23918K1088): solid Q1 2026, buyback boost and kidney care focus - AD HOC NEWS
Davita chief compliance officer James Hearty sells $2.9m in stock - Investing.com India
DaVita Inc (DVA) Stock Price, Trades & News - GuruFocus
Zacks.com featured highlights include DaVita, Antero Resources, PBF Energy and Popular - Yahoo Finance Singapore
DaVita stock (US23918K1088): dialysis provider in focus after strong share price run - AD HOC NEWS
DaVita Inc. (DVA) Investor Outlook: Navigating Growth with Robust Returns and Strategic Positioning - DirectorsTalk Interviews
How Investors Are Reacting To DaVita (DVA) Q1 Earnings Beat And Aggressive Share Buybacks - Sahm
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
2.33%
0.42%
大文字化:
|
ボリューム (24 時間):